Search

everythinglearnresearchcommunity

for

Search:↓

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Skin stem cells are crucial for maintaining and repairing skin, with potential for treating skin disorders and improving wound healing.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Over 60% of Korean military personnel had skin diseases, commonly acne and athlete's foot, linked to service length and stress.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Lupus patients' body image issues significantly affect their mental health and need more support.

Surgery to fix a broken upper arm bone can sometimes lead to nerve damage.